Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Frigerio S"" wg kryterium: Wszystkie pola

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 2423
Tytuł:
Long-Term Vocational Outcome at 15 Years from Severe Traumatic and Non-Traumatic Brain Injury in Pediatric Age.
Autorzy:
Strazzer S; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Pastore V; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Frigerio S; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Colombo K; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Galbiati S; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Locatelli F; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Galbiati S; Acquired Brain Injury Unit, Scientific Institute IRCCS E. Medea, 22040 Bosisio Parini, Italy.
Pokaż więcej
Źródło:
Brain sciences [Brain Sci] 2023 Jun 28; Vol. 13 (7). Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
miR-146a-5p impairs melanoma resistance to kinase inhibitors by targeting COX2 and regulating NFkB-mediated inflammatory mediators.
Autorzy:
Vergani E; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Dugo M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy.
Cossa M; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Frigerio S; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Di Guardo L; Unit of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gallino G; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Mattavelli I; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Vergani B; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Lalli L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Tamborini E; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Valeri B; Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Gargiuli C; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy.
Shahaj E; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Ferrarini M; Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy.
Ferrero E; Experimental Oncology, San Raffaele Scientific Institute, Milan, Italy.
Gomez Lira M; Biology and Genetics, Department of Neurosciences Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
Huber V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Del Vecchio M; Unit of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Sensi M; Platform of Integrated Biology, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori AmadeoLab, Milan, Italy.
Leone BE; Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Santinami M; Melanoma and Sarcoma Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Rivoltini L; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Rodolfo M; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.
Vallacchi V; Unit of Immunotherapy of Human Tumors, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy. .
Pokaż więcej
Źródło:
Cell communication and signaling : CCS [Cell Commun Signal] 2020 Sep 23; Vol. 18 (1), pp. 156. Date of Electronic Publication: 2020 Sep 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Neoplasm*/drug effects
Drug Resistance, Neoplasm*/genetics
Cyclooxygenase 2/*metabolism
Inflammation Mediators/*metabolism
Melanoma/*drug therapy
Melanoma/*genetics
MicroRNAs/*metabolism
NF-kappa B/*metabolism
Protein Kinase Inhibitors/*therapeutic use
Cell Line, Tumor ; Cyclooxygenase 2/genetics ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Melanoma/pathology ; MicroRNAs/genetics ; Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors ; Mitogen-Activated Protein Kinase Kinases/metabolism ; Models, Biological ; Protein Kinase Inhibitors/pharmacology ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors ; Proto-Oncogene Proteins B-raf/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms.
Autorzy:
Frigerio S; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.; Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Lartey DA; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.; Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
D'Haens GR; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Grootjans J; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.; Tytgat Institute for Liver and Intestinal Research, Amsterdam University Medical Centers, Location AMC, 1105 AZ Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 25; Vol. 22 (23). Date of Electronic Publication: 2021 Nov 25.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Tumor Microenvironment*
Colorectal Neoplasms/*pathology
Immune System/*immunology
Immunosuppressive Agents/*therapeutic use
Inflammatory Bowel Diseases/*complications
Animals ; Colorectal Neoplasms/drug therapy ; Colorectal Neoplasms/etiology ; Colorectal Neoplasms/metabolism ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Dendritic Cells and Cancer Immunotherapy: The Adjuvant Effect.
Autorzy:
Nava S; Cell Therapy Production Unit, Neurology Unit, UCV, Neurological Institute 'C. Besta' IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy.
Lisini D; Cell Therapy Production Unit, Neurology Unit, UCV, Neurological Institute 'C. Besta' IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy.
Frigerio S; Cell Therapy Production Unit, Neurology Unit, UCV, Neurological Institute 'C. Besta' IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy.
Bersano A; Cell Therapy Production Unit, Neurology Unit, UCV, Neurological Institute 'C. Besta' IRCCS Foundation, Via Celoria 11, 20133 Milan, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Nov 15; Vol. 22 (22). Date of Electronic Publication: 2021 Nov 15.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Adjuvants, Immunologic/*therapeutic use
Cancer Vaccines/*therapeutic use
Dendritic Cells/*immunology
Immune Checkpoint Inhibitors/*therapeutic use
Immunotherapy, Adoptive/*methods
Neoplasms/*drug therapy
Neoplasms/*radiotherapy
Animals ; Antigens, Neoplasm/immunology ; Cancer Vaccines/immunology ; Combined Modality Therapy/methods ; Humans ; Neoplasms/immunology ; Progression-Free Survival ; Tumor Escape/drug effects ; Tumor Escape/radiation effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach.
Autorzy:
Lisini D; Cell Therapy Production Unit-UPTC and Cerebrovascular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Lettieri S; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Nava S; Cell Therapy Production Unit-UPTC and Cerebrovascular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Accordino G; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Frigerio S; Cell Therapy Production Unit-UPTC and Cerebrovascular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, 20133 Milan, Italy.
Bortolotto C; Unit of Radiology, Department of Intensive Medicine, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Lancia A; Unit of Radiation Therapy, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Filippi AR; Unit of Radiation Therapy, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Agustoni F; Unit of Oncology, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Pandolfi L; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Piloni D; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Comoli P; Cell Factory and Pediatric Hematology-Oncology Unit, IRCCS Fondazione Policlinico San Matteo, 27100 Pavia, Italy.
Corsico AG; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Stella GM; Unit of Respiratory Diseases, Department of Medical Sciences and Infective Diseases, IRCCS Policlinico San Matteo Foundation and University of Pavia Medical School, 27100 Pavia, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 20; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Mesothelioma, Malignant/*pathology
Mesothelioma, Malignant/*therapy
Combined Modality Therapy ; Drug Delivery Systems/methods ; Humans ; Immunotherapy/methods ; Mesothelioma/pathology ; Mesothelioma/therapy ; Pleural Neoplasms/pathology ; Pleural Neoplasms/therapy ; Soft Tissue Neoplasms/pathology ; Soft Tissue Neoplasms/therapy ; Tumor Microenvironment/drug effects ; Tumor Microenvironment/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 2423

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies